US Stock MarketDetailed Quotes

Monopar Therapeutics (MNPR)

Watchlist
  • 61.260
  • -3.140-4.88%
Close Jun 2 16:00 ET
410.38MMarket Cap-31.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monopar Therapeutics (MNPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
62.18%5.23M
3.36%16.7M
-44.42%6.16M
159.89%4.09M
80.81%3.23M
86.95%3.22M
83.01%16.16M
479.22%11.07M
-23.77%1.57M
-23.17%1.79M
Selling and administrative expenses
10.11%1.74M
115.49%6.8M
92.53%2.21M
154.53%1.5M
128.68%1.5M
108.44%1.58M
-2.33%3.16M
31.22%1.15M
-21.19%590.62K
-10.32%657.81K
-General and administrative expense
10.11%1.74M
115.49%6.8M
92.53%2.21M
154.53%1.5M
128.68%1.5M
108.44%1.58M
-2.33%3.16M
31.22%1.15M
-21.19%590.62K
-10.32%657.81K
Research and development costs
112.20%3.49M
-23.85%9.9M
-60.29%3.94M
163.11%2.59M
52.96%1.73M
70.10%1.64M
132.24%13.01M
858.35%9.92M
-25.24%984.28K
-29.08%1.13M
Operating profit
-62.18%-5.23M
-3.36%-16.7M
44.42%-6.16M
-159.89%-4.09M
-80.81%-3.23M
-86.95%-3.22M
-83.01%-16.16M
-479.22%-11.07M
23.77%-1.57M
23.17%-1.79M
Net non-operating interest income expense
123.21%1.33M
639.45%2.99M
540.41%954.43K
559.80%655.47K
962.63%780.77K
626.40%596.85K
-5.83%404.02K
51.96%149.04K
-11.51%99.34K
-42.70%73.48K
Non-operating interest income
123.21%1.33M
639.45%2.99M
540.41%954.43K
559.80%655.47K
962.63%780.77K
626.40%596.85K
-5.83%404.02K
51.96%149.04K
-11.51%99.34K
-42.70%73.48K
Other net income (expense)
171.28K
0
171.28K
Other non- operating income (expenses)
----
----
----
----
----
----
--171.28K
--0
--171.28K
----
Income before tax
-48.31%-3.89M
11.99%-13.72M
52.40%-5.2M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
Income tax
Net income
-48.31%-3.89M
11.99%-13.72M
52.40%-5.2M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
Net income continuous Operations
-48.31%-3.89M
11.99%-13.72M
52.40%-5.2M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
Minority interest income
Net income attributable to the parent company
-48.31%-3.89M
11.99%-13.72M
52.40%-5.2M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.31%-3.89M
11.99%-13.72M
52.40%-5.2M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
Basic earnings per share
-21.05%-0.46
54.99%-1.85
76.73%-0.64
-29.73%-0.48
28.57%-0.35
25.49%-0.38
-35.20%-4.11
-350.82%-2.75
46.38%-0.37
38.75%-0.49
Diluted earnings per share
-21.05%-0.46
54.99%-1.85
76.73%-0.64
-29.73%-0.48
28.57%-0.35
25.49%-0.38
-35.20%-4.11
-350.82%-2.75
46.38%-0.37
38.75%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 62.18%5.23M3.36%16.7M-44.42%6.16M159.89%4.09M80.81%3.23M86.95%3.22M83.01%16.16M479.22%11.07M-23.77%1.57M-23.17%1.79M
Selling and administrative expenses 10.11%1.74M115.49%6.8M92.53%2.21M154.53%1.5M128.68%1.5M108.44%1.58M-2.33%3.16M31.22%1.15M-21.19%590.62K-10.32%657.81K
-General and administrative expense 10.11%1.74M115.49%6.8M92.53%2.21M154.53%1.5M128.68%1.5M108.44%1.58M-2.33%3.16M31.22%1.15M-21.19%590.62K-10.32%657.81K
Research and development costs 112.20%3.49M-23.85%9.9M-60.29%3.94M163.11%2.59M52.96%1.73M70.10%1.64M132.24%13.01M858.35%9.92M-25.24%984.28K-29.08%1.13M
Operating profit -62.18%-5.23M-3.36%-16.7M44.42%-6.16M-159.89%-4.09M-80.81%-3.23M-86.95%-3.22M-83.01%-16.16M-479.22%-11.07M23.77%-1.57M23.17%-1.79M
Net non-operating interest income expense 123.21%1.33M639.45%2.99M540.41%954.43K559.80%655.47K962.63%780.77K626.40%596.85K-5.83%404.02K51.96%149.04K-11.51%99.34K-42.70%73.48K
Non-operating interest income 123.21%1.33M639.45%2.99M540.41%954.43K559.80%655.47K962.63%780.77K626.40%596.85K-5.83%404.02K51.96%149.04K-11.51%99.34K-42.70%73.48K
Other net income (expense) 171.28K0171.28K
Other non- operating income (expenses) --------------------------171.28K--0--171.28K----
Income before tax -48.31%-3.89M11.99%-13.72M52.40%-5.2M-163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M
Income tax
Net income -48.31%-3.89M11.99%-13.72M52.40%-5.2M-163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M
Net income continuous Operations -48.31%-3.89M11.99%-13.72M52.40%-5.2M-163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M
Minority interest income
Net income attributable to the parent company -48.31%-3.89M11.99%-13.72M52.40%-5.2M-163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.31%-3.89M11.99%-13.72M52.40%-5.2M-163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M
Basic earnings per share -21.05%-0.4654.99%-1.8576.73%-0.64-29.73%-0.4828.57%-0.3525.49%-0.38-35.20%-4.11-350.82%-2.7546.38%-0.3738.75%-0.49
Diluted earnings per share -21.05%-0.4654.99%-1.8576.73%-0.64-29.73%-0.4828.57%-0.3525.49%-0.38-35.20%-4.11-350.82%-2.7546.38%-0.3738.75%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.78%
Sample Name
Sample Code
 +2.92%
Sample Name
Sample Code
 -2.94%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-3.11%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
-4.51%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +31.53%
Sample Name
Sample Code
 +30.90%
Sample Name
Sample Code
 +22.86%
4
Pony AI
PONY
+15.95%
5
NIO Inc
NIO
+14.26%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The situation in the Middle East has seen repeated twists and turns. On June 2 (Eastern Time), Iranian media reported that indirect communic Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -